I think that you'll find that Cardiocel 3d is already specifically targeting neonatal patients:
From announcement on 2 May:
As there are virtually no flat surfaces in the vascular or cardiac structure, this unique 60 shaped collagen product targets complex neonatal arch and pulmonary artery repair and is intended to help optimize suturing of central and extra-cardiac shunts. Its dimensions and specifications are designed to ‘mate’ with the triple plane anatomy found in neonatal arch and pulmonary artery repairs.
I suspect that feasability studies to control thickness could also address the study results, as described in the webinar presentation:
§ Control of ADAPT® scaffold thickness:
First automated machine prototype complete
Processed a pericardium sheet from .5mm to .3mm
Processed a porton of a pericardium sheet as low as .15mm
Capability to produce two different thickness levels in same sheet
exee
- Forums
- ASX - By Stock
- Ann: Admedus announces facility agreement with PFG
I think that you'll find that Cardiocel 3d is already...
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$10.75 |
Change
-0.110(1.01%) |
Mkt cap ! $227.2M |
Open | High | Low | Value | Volume |
$10.95 | $10.95 | $10.24 | $285.2K | 26.69K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $10.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.75 | 413 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 10.490 |
2 | 1097 | 10.300 |
4 | 4003 | 10.200 |
1 | 500 | 10.150 |
2 | 1450 | 10.100 |
Price($) | Vol. | No. |
---|---|---|
10.750 | 413 | 1 |
10.950 | 4 | 1 |
11.000 | 3758 | 1 |
11.800 | 200 | 1 |
12.000 | 5000 | 1 |
Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |